Dr. Daniel Thurley, general manager of Roche Hong Kong and Macau, shares his first impressions of the affiliate, the strategic significance of Hong Kong to Roche globally, the innovative medicines and technology Roche is committed to bringing to Hong Kong, and his insights on Roche’s commitment to patient-centricity.
There have been significant milestones for Roche and Hong Kong in the past year, with global CEO Severin Schwan visiting the Hong Kong affiliate in 2017 and Hong Kong Chief Executive (CE) visiting Roche’s global headquarters in Basel during her 2018 Switzerland trip. What does this indicate about the strategic significance of Roche Hong Kong?
"The opportunities that Hong Kong offers within the healthcare and life sciences sector are unique globally."
